Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab and Actinomycin-D in GTN (FIGO 7)
NCT06020755Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of toripalimab in gestational trophoblastic neoplasia (GTN), sponsored by Peking Union Medical College Hospital. Started Dec 2024; status: recruiting.
02
Drugs
toripalimab
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT06020755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020755.